Cross Border
-
Opioid drugs made John Kapoor a billionaire, but has he breached ethical limits?
John Kapoor made his billions by letting his drug companies push legal and ethical limits—which was fine when he was peddling blood-pressure pills, but not once he started selling one of the strongest narcotics in the world
-
Director Renny Harlin makes blockbuster China debut
Renny Harlin scores a hit with Jackie Chan and pulls up roots in the process
-
Blade runners: How US startup Harry's plans to go after Gillette
Harry's built an old-school shaving brand through online subscription boxes. Now it's targeting a bigger market
-
Property tycoon Cecil Chao and daughter make a tight knit team
Has any dad embarrassed his daughter more than Cecil Chao? No matter. He and Gigi make a tight-knit team at their Hong Kong property developer, Cheuk Nang Holdings
-
How Garmin mapped out a new direction with fitness wearables
Smartphone navigation apps threatened to push Garmin off the road. To survive, it has shifted to wearables and relied on decades of manufacturing experience to catch up
-
A step above: Shoemaker Jack Erwin is disrupting the market for affordable footwear
Three-year-old shoemaker Jack Erwin disrupted the footwear market by cutting out the middleman. Can it make the next leap forward?
-
Chinese tourists win big for Australian casinos
Flush from a run at the Asian VIP casino take, Aussie operators gird for a wider resorts battle
-
GlaxoSmithKline takes its medicines: How Andrew Witty patched up the sick drugmaker
Andrew Witty inherited a drugmaker sick with scandal and spent the next eight years patching up his patient. GlaxoSmithKline may finally be well again
-
The Wizard of Apps: How Jeff Lawson built Twilio into the mightiest unicorn
The hottest stock in America, Twilio, is a company you've never heard of. It uses the cloud to put communications everywhere
-
Vegan veteran Follow Your Heart wakes up to VC-backed competitors
For more than 40 years Follow Your Heart has been quietly selling health-conscious foods. Now VCs are backing fast-growing competitors
